On-Call Scheduling Software Market: Global Industry Research Report 2020-2027 | Envisage Research

On-Call Scheduling Software Market - By Component (Solutions, Services) By Deployment (Cloud-based, On-premise) By Application (Business, Medical Use, Others) By Regional (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) - Industry Analysis, Opportunity and Forecast 2020 To 2027

Published Date: May 2021

No. of Pages: 198

Status: Published

Report Code: EMR100582

The global on-call scheduling software market size was valued at USD 1.32 billion in 2020 and is expected reach USD 9.08 billion expand at a compound annual growth rate (CAGR) of 31.6% from 2020 to 2027. The promising market growth prospects can be attributed to the increasing need for automation of staffing and on-call communication.

On-call scheduling software enables businesses to reach out to their staff quickly. Moreover, auto-rotation features in these solutions help businesses effectively manage their staff or resources. On-call scheduling solutions help businesses in combining real-time shift calendars of employees with integrated on-call notifications while also keeping track of employee shifts for a day or a rotating schedule with the help of numerous calendar views. The software also sets quotas to ensure minimum employee staffing requirements are met based on role, number of employees, skill, and certification. The software supports businesses in notifying their employees with the right message at the right time.

Businesses are focusing on integrating on-call scheduling software into their business operations to drive business productivity. Moreover, the integration of these solutions with alerting and monitoring systems leads to more efficient teams. Admins are increasingly using on-call scheduling software to easily maintain employee shifts around the calendar to ensure there are no work gaps in coverage. Furthermore, these software solutions allow colleagues to collaborate in real-time across multiple channels.

Robotic Process Automation (RPA) is one of the major trends observed in the on-call scheduling software market. RPA bridges the gap between the convenience of automated scheduling and personalized customer service. RPA tools help clients get personalized answers to their questions, helping them with scheduling appointments and providing other necessary information from chatbots or another RPA. Clients can get the information or help that they need in real-time or when they need it.

A lack of data network infrastructure across organizations is expected to hamper the market growth. The key challenge for on-call scheduling software processes is the limited usage of and knowledge about these scheduling systems. Software businesses from various industries also face challenges related to data acquisition, compute provisioning and management, data storage architectures, networks and communication, computing platforms, and data analytics. The aforementioned factors are expected to hamper the market growth.

Key companies are: 1Call - Division of AMTELCO; Adjuvant Technologies, LLC; Ambs Call Center, Central Logic Inc.; Everbridge, Inc.; Kronos Incorporated; Lightning Bolt Solutions; MDsyncNET; OpenTempo; ServiceNow, Inc.; Shift Administrators LLC; Spok, Inc.

Analyst Commentary

In 2019, the solutions segment dominated the market with a revenue share of more than 60.0%. The segment is likely to exhibit promising growth prospects in near future, owing to the increasing adoption of on-call scheduling solutions by organizations and hospitals to resolve critical issues such as system downtime and patient care delays. These solutions make it easy to view, update, and create schedule coverage for any department of an organization. Moreover, they simplify the scheduling process with the help of modifying schedules and easily dispatch messages to scheduled contacts.

The on-premise segment dominated the market in 2019 with a revenue share of more than 59.0%. Numerous companies still prefer to deploy solutions on-premise. Several companies also prefer to manage their data centres in-house. These companies choose to deploy solutions on-premise to aid in managing employee operations and maintain control over all systems and data.

The medical use segment dominated the market with more than a 48.0% revenue share in 2019. On-call scheduling software solutions are being widely used in medical applications as they allow healthcare organizations to manage complex clinical work more effectively. These solutions automate the process of clinical and on-call staff schedule publication, creation, and management across departments and specialties. These solutions also act as a centralized schedule management center, which clinicians can access directly from their mobile devices.

Segmentation

The On-Call Scheduling Software Market is segmented on the basis of component, deployment and application and region. On the basis of component Solutions, Services. On the basis of deployment Cloud-based, On-premise. On the basis of application Business, Medical Use, Others.

Regional Analysis

The North American region dominated the market in 2019 and accounted for over 30.0% share of global revenue. The growth can be attributed to the presence of several prominent vendors in the region, such as Everbridge, Inc.; ServiceNow, Inc.; and Spok, Inc. Businesses in this region are striving to improve business process efficiency, reduce costs, and enhance the productivity of their employees. This, in turn, is expected to create growth opportunities for regional market growth.

Asia Pacific is expected to register the highest CAGR over the forecast period. In the region, changes in consumer behaviour patterns across numerous business sectors, such as corporates and hospitals, have compelled organizations to adopt digitalization in their businesses. This, as a result, is expected to create growth opportunities for cloud-based on-call scheduling software in the region. A large number of small and medium enterprises in the region are focusing on reducing their administration cost, thereby creating growth opportunities for the regional market.

TABLE OF CONTENTS
Chapter 1. Executive Summary
Chapter 2. Research Methodology
2.1. Research approach
2.2. Scope, definition, and assumptions
2.3. Data Component
2.3.1. Secondary Component
2.3.1.1. Preliminary data mining
2.3.2. Primary Component
2.3.2.1. Statistical Model
2.3.2.2. Data Triangulation
2.3.2.3. Research Objective
Chapter 3. Market Outlook
3.1. Introduction
3.2. Key trends
3.2.1. xx
3.3. Market drivers
3.3.1. Impact analysis of Market Drivers
3.4. Market restraints
3.4.1. Impact analysis of Market Restraints
3.5. Market opportunities
3.5.1. Impact analysis of Market Opportunities
3.6. Market Challenges
3.6.1. Impact analysis of Market Trends
3.7. Porter’s Five Forces’ analysis
3.7.1. Bargaining Power of Suppliers
3.7.2. Bargaining Power of Buyers
3.7.3. Threat of New Entrant
3.7.4. Threat of Substitutes
3.7.5. High Competitive Rivalry
3.8. Value chain analysis
Chapter 4. COVID-19 Impact On Nuclear Medicine Market
Chapter 5. Global Nuclear Medicine Market Overview, By Type, 2015 - 2027(USD Million)
5.1. Global Nuclear Medicine Market Share, By Type, 2015 - 2027 (USD Million)
5.1.1. Diagnostic Nuclear Medicine
5.1.1.1. Market Type and Projections,2015 - 2027 (USD Million)
5.1.1.2. Market Type and Projections, by Region, 2015 - 2027 (USD Million)
5.1.2. Therapeutic Nuclear Medicine
5.1.2.1. Market Type and Projections,2015 - 2027 (USD Million)
5.1.2.2. Market Type and Projections, by Region, 2015 - 2027 (USD Million)
5.1.3. Brachytherapy Isotopes
5.1.3.1. Market Type and Projections,2015 - 2027 (USD Million)
5.1.3.2. Market Type and Projections, by Region, 2015 - 2027 (USD Million)
Chapter 6. Global Nuclear Medicine Market Overview, By Application, 2015 - 2027(USD Million)
6.1. Global Nuclear Medicine Market Share, By Application, 2015 - 2027 (USD Million)
6.1.1. Diagnostic
6.1.1.1. Market Type and Projections,2015 - 2027 (USD Million)
6.1.1.2. Market Type and Projections, by Region, 2015 - 2027 (USD Million)
6.1.2. PET
6.1.2.1. Market Type and Projections, 2015 - 2027 (USD Million)
6.1.2.2. Market Type and Projections, by Region, 2015 - 2027 (USD Million)
6.1.3. Therapeutic
6.1.3.1. Market Type and Projections, 2015 - 2027 (USD Million)
6.1.3.2. Market Type and Projections, by Region, 2015 - 2027 (USD Million)
Chapter 7. Global Nuclear Medicine Market Overview, By Procedural Volume Assessment, 2015 - 2027(USD Million)
7.1. Global Nuclear Medicine Market Share, By Procedural Volume Assessment, 2015 - 2027 (USD Million)
7.1.1. Diagnostic Procedures
7.1.1.1. Market Type and Projections,2015 - 2027 (USD Million)
7.1.1.2. Market Type and Projections, by Region, 2015 - 2027 (USD Million)
7.1.2. Therapeutic Procedures
7.1.2.1. Market Type and Projections, 2015 - 2027 (USD Million)
7.1.2.2. Market Type and Projections, by Region, 2015 - 2027 (USD Million)
Chapter 8. Global Nuclear Medicine Market Overview, By Geography, 2015 - 2027(USD Million)
8.1. Global Nuclear Medicine Market Share, By Geography, 2015 - 2027(USD Million)
8.1.1. Market Type and projections, by Countries, 2015 - 2027 (USD Million)
8.1.2. Market Share and CAGR Comparison, by Countries, 2020 - 2027 (%)
Chapter 9. North America Nuclear Medicine Market Overview, By Countries, 2015 - 2027(USD Million)
9.1. North America Nuclear Medicine Market Overview, 2015 - 2027 (USD Million)
9.1.1. Market Type and projections, 2015 - 2027 (USD Million)
9.1.2. North America Nuclear Medicine Market Overview, By Type, 2015 - 2027 (USD Million)
9.1.3. North America Nuclear Medicine Market Overview, By Application, 2015 - 2027 (USD Million)
9.1.4. North America Nuclear Medicine Market Overview, By Procedural Volume Assessment, 2015 - 2027 (USD Million)
9.1.5. North America Nuclear Medicine Market Overview, By Countries, 2015 - 2027 (USD Million)
9.1.5.1. U.S. Nuclear Medicine Market Overview, 2015 - 2027 (USD Million)
9.1.5.1.1. Market Type and projections, 2015 - 2027 (USD Million)
9.1.5.1.2. U.S. Nuclear Medicine Market Overview, By Type, 2015 - 2027 (USD Million)
9.1.5.1.3. U.S. Nuclear Medicine Market Overview, By Application, 2015 - 2027 (USD Million)
9.1.5.1.4. Other Segment
9.1.5.2. Canada Nuclear Medicine Market Overview, 2015 - 2027 (USD Million)
9.1.5.2.1. Market Type and projections, 2015 - 2027 (USD Million)
9.1.5.2.2. Canada Nuclear Medicine Market Overview, By Type, 2015 - 2027 (USD Million)
9.1.5.2.3. Canada Nuclear Medicine Market Overview, By Application, 2015 - 2027 (USD Million)
9.1.5.2.4. Other Segment
9.1.5.3. Mexico Nuclear Medicine Market Overview, 2015 - 2027 (USD Million)
9.1.5.3.1. Market Type and projections, 2015 - 2027 (USD Million)
9.1.5.3.2. Mexico Nuclear Medicine Market Overview, By Type, 2015 - 2027 (USD Million)
9.1.5.3.3. Mexico Nuclear Medicine Market Overview, By Application, 2015 - 2027 (USD Million)
9.1.5.3.4. Other Segment
Chapter 10. Europe Nuclear Medicine Market Overview, By Countries, 2015 - 2027(USD Million)
10.1. Europe Nuclear Medicine Market Overview, 2015 - 2027 (USD Million)
10.1.1. Market Type and projections, 2015 - 2027 (USD Million)
10.1.2. Europe Nuclear Medicine Market Overview, By Type, 2015 - 2027 (USD Million)
10.1.3. Europe Nuclear Medicine Market Overview, By Application, 2015 - 2027 (USD Million)
10.1.4. Europe Nuclear Medicine Market Overview, By Procedural Volume Assessment,2015 - 2027 (USD Million)
10.1.5. Europe Skin Care Types Market Overview, By Countries, 2015 - 2027 (USD Million)
10.1.5.1. Germany
10.1.5.1.1. Market Type and projections, 2015 - 2027 (USD Million)
10.1.5.1.2. Germany Nuclear Medicine Market Overview, By Type, 2015 - 2027(USD Million)
10.1.5.1.3. Germany Nuclear Medicine Market Overview, By Application, 2015 - 2027(USD Million)
10.1.5.1.4. Other Segments
10.1.5.2. France
10.1.5.2.1. Market Type and projections, 2015 - 2027 (USD Million)
10.1.5.2.2. France Nuclear Medicine Market Overview, By Type, 2015 - 2027(USD Million)
10.1.5.2.3. France Nuclear Medicine Market Overview, By Application, 2015 - 2027(USD Million)
10.1.5.2.4. Other Segments
10.1.5.3. UK
10.1.5.3.1. Market Type and projections, 2015 - 2027 (USD Million)
10.1.5.3.2. UK Nuclear Medicine Market Overview, By Type, 2015 - 2027(USD Million)
10.1.5.3.3. UK Nuclear Medicine Market Overview, By Application, 2015 - 2027(USD Million)
10.1.5.3.4. Other Segments
10.1.5.4. Italy
10.1.5.4.1. Market Type and projections, 2015 - 2027 (USD Million)
10.1.5.4.2. Italy Nuclear Medicine Market Overview, By Type, 2015 - 2027(USD Million)
10.1.5.4.3. Italy Nuclear Medicine Market Overview, By Application 2015 - 2027(USD Million)
10.1.5.4.4. Other Segments
10.1.5.5. Spain
10.1.5.5.1. Market Type and projections, 2015 - 2027 (USD Million)
10.1.5.5.2. Spain Nuclear Medicine Market Overview, By Type, 2015 - 2027(USD Million)
10.1.5.5.3. Spain Nuclear Medicine Market Overview, By Application, 2015 - 2027(USD Million)
10.1.5.5.4. Other Segments
10.1.5.6. Rest of Europe
10.1.5.6.1. Market Type and projections, 2015 – 2027
10.1.5.6.2. Rest of Europe Nuclear Medicine Market Overview, By Type, 2015 - 2027(USD Million)
10.1.5.6.3. Rest of Europe Nuclear Medicine Market Overview, By Application, 2015 - 2027(USD Million)
10.1.5.6.4. Other Segments
Chapter 11. Asia Pacific Nuclear Medicine Market Overview, By Countries, 2015 - 2027 (USD Million)
11.1. Asia Pacific Nuclear Medicine Market Overview, 2015 - 2027 (USD Million)
11.1.1. Market Type and projections, 2015 - 2027 (USD Million)
11.1.2. Asia Pacific Nuclear Medicine Market Overview, By Type, 2015 - 2027 (USD Million)
11.1.3. Asia Pacific Nuclear Medicine Market Overview, By Application, 2015 - 2027 (USD Million)
11.1.4. Asia Pacific Nuclear Medicine Market Overview, By Procedural Volume Assessment,2015 - 2027 (USD Million)
11.1.5. Asia Pacific Nuclear Medicine Market Overview, By Countries, 2015 - 2027 (USD Million)
11.1.5.1. India
11.1.5.1.1. Market Type and projections, 2015 - 2027 (USD Million)
11.1.5.1.2. India Nuclear Medicine Market Overview, By Type, 2015 - 2027(USD Million)
11.1.5.1.3. India Nuclear Medicine Market Overview, By Application, 2015 - 2027 (USD Million)
11.1.5.1.4. Other Segments
11.1.5.2. China
11.1.5.2.1. Market Type and projections, 2015 - 2027(USD Million)
11.1.5.2.2. China Nuclear Medicine Market Overview, By Type, 2015 - 2027(USD Million)
11.1.5.2.3. China Nuclear Medicine Market Overview, By Application, 2015 - 2027 (USD Million)
11.1.5.2.4. Other Segments
11.1.5.3. Japan
11.1.5.3.1. Market Type and projections, 2015 - 2027 (USD Million)
11.1.5.3.2. Japan Nuclear Medicine Market Overview, By Type, 2015 - 2027(USD Million)
11.1.5.3.3. Japan Nuclear Medicine Market Overview, By Application, 2015 - 2027(USD Million)
11.1.5.3.4. Other Segments
11.1.5.4. South Korea
11.1.5.4.1. Market Type and projections, 2015 - 2027(USD Million)
11.1.5.4.2. South Korea Nuclear Medicine Market Overview, By Type, 2015 - 2027(USD Million)
11.1.5.4.3. South Korea Nuclear Medicine Market Overview, By Application, 2015 - 2027 (USD Million)
11.1.5.4.4. Other Segments
11.1.5.5. Rest of Asia Pacific
11.1.5.5.1. Market Type and projections, 2015 - 2027 (USD Million)
11.1.5.5.2. Rest of Asia Pacific Nuclear Medicine Market Overview, By Type, 2015 - 2027(USD Million)
11.1.5.5.3. Rest of Asia Pacific Nuclear Medicine Market Overview, By Application, 2015 - 2027 (USD Million)
11.1.5.5.4. Other Segments
Chapter 12. Middle East & Africa Nuclear Medicine Market Overview, By Countries, 2015 - 2027 (USD Million)
12.1. Middle East & Africa Nuclear Medicine Market Overview, 2015 - 2027 (USD Million)
12.1.1. Market Type and projections, 2015 - 2027 (USD Million)
12.1.2. Middle East & Africa Nuclear Medicine Market Overview, By Type, 2015 - 2027 (USD Million)
12.1.3. Middle East & Africa Nuclear Medicine Market Overview, By Application, 2015 - 2027 (USD Million)
12.1.4. Middle East & Africa Nuclear Medicine Market Overview, By Procedural Volume Assessment,2015 - 2027 (USD Million)
12.1.5. Middle East & Africa Nuclear Medicine Market Overview, By Countries, 2015 - 2027 (USD Million)
12.1.5.1. GCC
12.1.5.1.1. Market Type and projections, 2015 - 2027 (USD Million)
12.1.5.1.2. GCC Nuclear Medicine Market Overview, By Type, 2015 - 2027 (USD Million)
12.1.5.1.3. GCC Nuclear Medicine Market Overview, By Application, 2015 - 2027 (USD Million)
12.1.5.1.4. Other Segments
12.1.5.2. South Africa
12.1.5.2.1. Market Type and projections, 2015 - 2027 (USD Million)
12.1.5.2.2. South Africa Nuclear Medicine Market Overview, By Type, 2015 - 2027 (USD Million)
12.1.5.2.3. South Africa Nuclear Medicine Market Overview, By Application, 2015 - 2027 (USD Million)
12.1.5.2.4. Other Segments
12.1.5.3. Rest of Middle East & Africa
12.1.5.3.1. Market Type and projections, 2015 - 2027 (USD Million)
12.1.5.3.2. Rest of Middle East & Africa Nuclear Medicine Market Overview, By Type, 2015 - 2027 (USD Million)
12.1.5.3.3. Rest of Middle East & Africa Nuclear Medicine Market Overview, By Application, 2015 - 2027 (USD Million)
12.1.5.3.4. Other Segments
Chapter 13. South America Nuclear Medicine Market Overview, By Countries, 2015 - 2027 (USD Million)
13.1. South America Nuclear Medicine Market Overview, 2015 - 2027 (USD Million)
13.1.1. Market Type and projections, 2015 - 2027 (USD Million)
13.1.2. South America Nuclear Medicine Market Overview, By Type, 2015 - 2027 (USD Million)
13.1.3. South America Nuclear Medicine Market Overview, By Application, 2015 - 2027 (USD Million)
13.1.4. South America Nuclear Medicine Market Overview, By Procedural Volume Assessment,2015 - 2027 (USD Million)
13.1.5. South America Nuclear Medicine Market Overview, By Countries, 2015- 2026 (USD Million)
13.1.6. Brazil
13.1.6.1. Market Type and projections, 2015 - 2027 (USD Million)
13.1.6.2. Brazil Nuclear Medicine Market Overview, By Type, 2015 - 2027 (USD Million)
13.1.6.3. Brazil Nuclear Medicine Market Overview, By Application, 2015 - 2027 (USD Million)
13.1.6.4. Other Segments
13.1.7. Argentina
13.1.7.1. Market Type and projections, 2015 - 2027 (USD Million)
13.1.7.2. Argentina Nuclear Medicine Market Overview, By Type, 2015 - 2027 (USD Million)
13.1.7.3. Argentina Nuclear Medicine Market Overview, By Application, 2015 - 2027 (USD Million)
13.1.7.4. Other Segments
13.1.8. Rest of South America
13.1.8.1. Market Type and projections, 2015 – 2027
13.1.8.2. Rest of South America Nuclear Medicine Market Overview, By Type, 2015 - 2027 (USD Million)
13.1.8.3. Rest of South America Nuclear Medicine Market Overview, By Application, 2015 - 2027 (USD Million)
13.1.8.4. Other Segments
Chapter 14. Competitive Landscape
14.1. Competitive environment, 2020
14.2. Strategic framework
14.2.1. Partnership/agreement
14.2.2. Expansion
14.2.3. Mergers & Acquisitions
14.2.4. New Type development
Chapter 15. Key Vendor Analysis
15.1. Cardinal Health
15.1.1. Company overview
15.1.2. Financial performance
15.1.3. Product Benchmarking
15.1.4. Recent initiatives
15.1.5. SWOT analysis
15.2. Curium
15.2.1. Company overview
15.2.2. Financial performance
15.2.3. Product Benchmarking
15.2.4. Recent initiatives
15.2.5. SWOT analysis
15.3. GE Healthcare
15.3.1. Company overview
15.3.2. Financial performance
15.3.3. Product Benchmarking
15.3.4. Recent initiatives
15.4. Lantheus Medical Imaging, Inc.
15.5. Bayer AG
15.6. Bracco Imaging S.P.A.
15.7. Eczacibasi-Monrol Nuclear Products
15.8. Nordion, Inc.
15.9. Advanced Accelerator Applications
15.10. NTP Radioisotopes Soc, LTD.
Chapter 16. Nuclear Medicine Market Cost Analysis
16.1. Nuclear Medicine Market Key Type Analysis
16.1.1. Key Type
16.1.2. Price Trend of Key Type
16.1.3. Key Suppliers of Type
16.1.4. Market Concentration Rate of Type
16.1.5. Labor Cost
Chapter 17. Sourcing Strategy and Downstream Buyers
17.1. Nuclear Medicine Market Chain Analysis
17.2. Upstream Type Sourcing
17.3. Nuclear Medicine Market Major Manufacturers in 2021
17.4. Downstream Buyers
Chapter 18. Marketing Strategy Analysis, Distributors/Traders
18.1. Marketing Channel
18.1.1. Direct Marketing
18.1.2. Indirect Marketing
18.1.3. Marketing Channel Development Trend
18.2. Market Positioning
18.2.1. Pricing Strategy
18.2.2. Brand Strategy
18.2.3. Target Client
18.3. Distributors/Traders List
Chapter 19. Market Effect Factors Analysis
19.1. Technology Progress/Risk
19.1.1. Substitutes Threat
19.1.2. Technology Progress in Related Type
19.2. Consumer Needs/Customer Preference Change
19.3. Economic/Political Environmental Change
Chapter 20. Future Outlook of the Market
Disclaimer 
List of Figures
1. Market segmentation
2. Value chain analysis
3. Porter’s Five Forces’ analysis
4. Power of Suppliers
5. Power of Buyers
6. Threat of New Entrants
7. Threat of Substitute
8. Competitive Rivalry
9. Global Nuclear Medicine Market share, By Type, 2020 & 2027 (%)
10. Global Nuclear Medicine Market share, by Diagnostic Nuclear Medicine, By Type, 2015 - 2027 (USD Million)
11. Global Nuclear Medicine Market share, by Therapeutic Nuclear Medicine, By Type, 2015 - 2027 (USD Million)
12. Global Nuclear Medicine Market share, by Brachytherapy Isotopes, By Type, 2015 - 2027 (USD Million)
13. Global Nuclear Medicine Market share, By Application, 2020 & 2027 (%)
14. Global Nuclear Medicine Market share, by Diagnostic, By Application, 2015 - 2027 (USD Million)
15. Global Nuclear Medicine Market share, by PET, By Application 2015 - 2027 (USD Million)
16. Global Nuclear Medicine Market share, by Therapeutic, By Application 2015 - 2027 (USD Million)
17. Global Nuclear Medicine Market share, By Procedural Volume Assessment, 2020 & 2027 (%)
18. Global Nuclear Medicine Market share, by Diagnostic Procedures, By Procedural Volume Assessment, 2015 - 2027 (USD Million)
19. Global Nuclear Medicine Market share, by Therapeutic Procedures, By Procedural Volume Assessment 2015 - 2027 (USD Million)
20. Global Nuclear Medicine Market share, by region, 2020 & 2027 (%)
21. Global Nuclear Medicine Market share, by region, 2015 - 2027(USD Million)
22. North America Nuclear Medicine Market, 2015 - 2027(USD Million)
23. North America Nuclear Medicine Market share, by Countries, 2020 & 2027 (%)
24. U.S. Nuclear Medicine Market, 2015 - 2027(USD Million)
25. Canada Nuclear Medicine Market, 2015 - 2027(USD Million)
26. Mexico Nuclear Medicine Market, 2015 - 2027(USD Million)
27. Europe Nuclear Medicine Market, 2015 - 2027(USD Million)
28. Europe Nuclear Medicine Market share, by Countries, 2020 & 2027 (%)
29. Spain Nuclear Medicine Market, 2015 - 2027(USD Million)
30. UK Nuclear Medicine Market, 2015 - 2027(USD Million)
31. Italy Nuclear Medicine Market, 2015 - 2027(USD Million)
32. Germany Nuclear Medicine Market, 2015 - 2027(USD Million)
33. France Nuclear Medicine Market, 2015 - 2027(USD Million)
34. Rest of Europe Nuclear Medicine Market, 2015 - 2027(USD Million)
35. Asia-Pacific Nuclear Medicine Market, 2015 - 2027(USD Million)
36. Asia-Pacific Nuclear Medicine Market share, by Countries, 2020 & 2027 (%)
37. China Nuclear Medicine Market, 2015 - 2027(USD Million)
38. India Nuclear Medicine Market, 2015 - 2027(USD Million)
39. Australia Nuclear Medicine Market, 2015 - 2027(USD Million)
40. Japan Nuclear Medicine Market, 2015 - 2027(USD Million)
41. Rest of Asia-Pacific Nuclear Medicine Market, 2015 - 2027(USD Million)
42. Middle East & Africa Nuclear Medicine Market, 2015 - 2027(USD Million)
43. Middle East & Africa Nuclear Medicine Market share, by Countries, 2020 & 2027 (%)
44. GCC Nuclear Medicine Market, 2015 - 2027(USD Million)
45. South Africa Nuclear Medicine Market, 2015 - 2027(USD Million)
46. Rest Of Middle East & Africa Nuclear Medicine Market, 2015 - 2027(USD Million)
47. South America Nuclear Medicine Market, 2015 - 2027(USD Million)
48. Brazil Nuclear Medicine Market, 2015 - 2027(USD Million)
49. Mexico Nuclear Medicine Market, 2015 - 2027(USD Million)
50. Argentina Nuclear Medicine Market, 2015 - 2027(USD Million)
51. Rest Of South America Nuclear Medicine Market, 2015 - 2027(USD Million)

List of Tables

1. Impact of Market drivers
2. Impact of Market restraints
3. Global Nuclear Medicine Market, 2015-2027 (USD Million)
4. Nuclear Medicine requirement, by country, 2015-2027, (USD Million)
5. North America Nuclear Medicine Market, By Type, 2015-2027 (USD Million)
6. North America Nuclear Medicine Market, By Application, 2015-2027 (USD Million)
7. North America Nuclear Medicine Market, By Procedural Volume Assessment, 2015-2027 (USD Million)
8. Europe Nuclear Medicine Market, By Type, 2015-2027 (USD Million)
9. Europe Nuclear Medicine Market, By Application, 2015-2027 (USD Million)
10. Europe Nuclear Medicine Market, By Procedural Volume Assessment, 2015-2027 (USD Million)
11. Asia Pacific Nuclear Medicine Market, By Type, 2015-2027 (USD Million)
12. Asia Pacific Nuclear Medicine Market, By Application, 2015-2027 (Revenue, USD Million)
13. Asia Pacific Nuclear Medicine Market, By Procedural Volume Assessment, 2015-2027 (Revenue, USD Million)
14. Middle East & Africa Nuclear Medicine Market, By Type, 2015-2027 (USD Million)
15. Middle East & Africa Nuclear Medicine Market, By Application, 2015-2027 (USD Million)
16. Middle East & Africa Nuclear Medicine Market, By Procedural Volume Assessment, 2015-2027 (USD Million)
17. South America Nuclear Medicine Market, By Type, 2015-2027 (USD Million)
18. South America Nuclear Medicine Market, By Application, 2015-2027 (USD Million)
19. South America Nuclear Medicine Market, By Procedural Volume Assessment, 2015-2027 (USD Million)
20. Global Nuclear Medicine Market, Company Market Share, 2020 - 2027 (%)
21. Cardinal Health : Deployment model Benchmarking
22. Cardinal Health : Financial Performance
23. Curium : Deployment model Benchmarking
24. Curium : Financial Performance
25. GE Healthcare: Deployment model Benchmarking
26. GE Healthcare : Financial Performance
27. Lantheus Medical Imaging, Inc.: Deployment model Benchmarking
28. Lantheus Medical Imaging, Inc.: Financial Performance
29. Bayer AG :Deployment model Benchmarking
30. Bayer AG : Financial Performance
31. Bracco Imaging S.P.A. : Deployment model Benchmarking
32. Bracco Imaging S.P.A. : Financial Performance
33. Eczacibasi-Monrol Nuclear Products : Product Benchmarking
34. Eczacibasi-Monrol Nuclear Products : Financial Performance
35. Nordion, Inc.: Product Benchmarking
36. Nordion, Inc.: Financial Performance
37. Advanced Accelerator Applications : Product Benchmarking
38. Advanced Accelerator Applications : Financial Performance
39. NTP Radioisotopes Soc, LTD. : Product Benchmarking
40. NTP Radioisotopes Soc, LTD. : Financial Performance

The Leading Key Players in On Call Scheduling Software Market

1Call - Division of AMTELCO
Adjuvant Technologies
LLC
Ambs Call Center
Central Logic Inc.
Everbridge Inc.
Kronos Incorporated
Lightning Bolt Solutions
MDsyncNET
OpenTempo
ServiceNow Inc.
Shift Administrators LLC
Spok Inc.